2025-09-28 - Analysis Report
Okay, here's an analysis of Starbucks (SBUX) based on the provided data.  The report is structured with numbers first, followed by analysis.

## Starbucks (SBUX) Stock Analysis

**Company Overview:** Starbucks Corp is a global coffeehouse chain that roasts, markets, and retails specialty coffee.

### 1. Relative Performance & Alpha/Beta Analysis

**Key Numbers:**

*   **Ticker:** SBUX
*   **SBUX Cumulative Return:** 9.40%
*   **VOO (S&P 500) Cumulative Return:** 66.41%
*   **Spread (SBUX - VOO):**
    *   Max: 28.3
    *   Min: -88.2
    *   Current: -73.1
    *   Relative Spread: 13.0

**Alpha, Beta Table:**

| Year       | CAGR    | MDD     | Alpha   | Beta | Cap(B) |
|------------|---------|---------|---------|------|--------|
| 2015-2017  | -1.0%  | 65.6%  | -10.0%  | 0.0  | 65.3  |
| 2016-2018  | -2.0%  | 64.5%  | 0.0%   | 0.1  | 73.2  |
| 2017-2019  | 51.0%  | 78.8%  | 47.0%  | 0.1  | 99.9  |
| 2018-2020  | 55.0%  | 80.3%  | 30.0%  | 0.2  | 121.6 |
| 2019-2021  | 23.0%  | 80.3%  | -6.0%  | 0.5  | 133.0 |
| 2020-2022  | -34.0% | 80.3%  | -48.0% | 0.7  | 112.8 |
| 2021-2023  | -43.0% | 82.1%  | -61.0% | 1.9  | 109.1 |
| 2022-2024  | -22.0% | 82.1%  | -35.0% | 1.9  | 103.7 |
| 2023-2025  | -6.0%  | 82.1%  | -41.0% | 3.2  | 94.8  |

**Analysis:**

*   **Underperformance:** SBUX has significantly underperformed the S&P 500 (VOO) over the period. The current cumulative return spread is heavily negative. The relative spread of 13.0 suggests the current spread is near the lower end of its historical range compared to VOO.
*   **Alpha/Beta Trends:** The Alpha values are largely negative, especially in recent years, indicating underperformance relative to the market's risk-adjusted return.  Beta has increased significantly in the more recent periods, suggesting SBUX's price is becoming increasingly sensitive to overall market movements.  The Maximum Drawdown (MDD) is high, indicating significant potential losses during the observed periods. The market cap is also showing a declining trend, indicating a shrinking valuation of the company.

### 2. Recent Price Action

**Key Numbers:**

*   **Last Price:** 83.39
*   **Previous Close:** 83.83
*   **Change:** -0.52
*   **5-day Moving Average:** 84.438
*   **20-day Moving Average:** 84.534
*   **60-day Moving Average:** 89.4432

**Analysis:**

*   **Short-Term Downtrend:** The stock is trading below its 5-day, 20-day, and 60-day moving averages, suggesting a short-term downtrend. The recent negative change of -0.52 reinforces this.
*   **Moving Averages:** The fact that the 5-day moving average is below the 20-day moving average, which is below the 60-day moving average, further confirms the downtrend.

### 3. Market Risk Indicators and Expected Return

**Key Numbers:**

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 46.14
*   **PPO:** 0.2873
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (1041 shares - Very Safe - MRI:0.90)
*   **Recent Change in Relative Spread (20-day):** -0.7 (Negative - Short-term Decline)
*   **Expected Return (%):** -287.4

**Analysis:**

*   **MRI Contradiction:**  The high MRI (0.9) suggests that the market conditions are generally favorable for investment. However, other indicators suggest caution.
*   **RSI:** An RSI of 46.14 is neutral, not indicating overbought or oversold conditions.
*   **PPO:** A PPO of 0.2873 is close to zero, suggesting that the short-term and long-term moving averages are relatively close to each other.
*   **Hybrid Signal:** Despite the risks, the hybrid signal suggests buying 100% of available cash, possibly due to the high MRI and considering it a "very safe" opportunity.
*   **Short-Term Decline:** The negative change in the relative spread confirms the recent underperformance.
*   **Very Negative Expected Return:** The expected return of -287.4% is extremely negative, suggesting significant underperformance compared to the S&P 500 if investing for the long term (2+ years). This is a critical warning sign.
*   **Price Change:** The price change of -0.52 from the previous close does indicate a minor fluctuation but it isn't significant enough to call it a sharp drop.

### 4. Recent News & Significant Events

*   **Store Closures and Restructuring:** Multiple news articles focus on Starbucks closing stores and slashing jobs as part of a restructuring plan. This is likely impacting investor sentiment negatively.
*   **Competition:**  News about Luckin Coffee's U.S. launch suggests increased competition in the coffee market.

**Impact:** The news flow is overwhelmingly negative, focusing on restructuring, job cuts, and store closures. The restructuring seems related to tariffs, boycotts, and policy backlash, according to one article. This is very concerning and likely contributing to the stock's underperformance.

### 4-2. Analyst Opinions

*   **Consensus:** The analyst consensus is a "Buy" with a mean rating of 2.34.
*   **Target Price:** The average target price is $98.47, significantly higher than the current price.  The range is wide ($73 - $115), indicating uncertainty among analysts.
*   **Recent Rating Changes:** No rating changes data provided.

**Analysis:**

*   **Analyst Optimism vs. Reality:** There is a disconnect between the negative news and the "Buy" consensus from analysts. This could mean analysts haven't fully factored in the restructuring impacts or are betting on a successful turnaround.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출      |
|------------|------|-----------|
| 2025-07-29 | 0.49 | 9.46 B$  |
| 2025-04-29 | 0.34 | 8.76 B$  |
| 2025-01-28 | 0.69 | 9.40 B$  |
| 2024-07-30 | 0.93 | 9.11 B$  |
| 2025-07-29 | 0.93 | 9.11 B$  |

**Analysis:**

*   **Recent EPS Decline:**  EPS appears to be declining, especially when comparing the most recent quarter (0.49) to earlier quarters (0.93).
*   **Revenue Fluctuations:** Revenue has fluctuated, but generally remains high, indicating that sales are still strong, despite the other negative factors.

### 6. Financial Information: Revenue, Profitability, Capital

| Quarter    | Revenue  | Profit Margin |
|------------|----------|---------------|
| 2025-06-30 | $9.46B   | 22.80%        |
| 2025-03-31 | $8.76B   | 21.09%        |
| 2024-12-31 | $9.40B   | 24.49%        |
| 2024-09-30 | $9.07B   | 26.25%        |
| 2024-06-30 | $9.11B   | 27.91%        |

| Quarter    | Equity    | ROE       |
|------------|-----------|-----------|
| 2025-06-30 | $-7.69B  | -7.26%    |
| 2025-03-31 | $-7.62B  | -5.04%    |
| 2024-12-31 | $-7.47B  | -10.45%   |
| 2024-09-30 | $-7.45B  | -12.21%   |
| 2024-06-30 | $-7.95B  | -13.28%   |

**Analysis:**

*   **Declining Profit Margins:** Profit margins have been declining steadily over the past five quarters, indicating that the company is becoming less efficient in converting revenue into profit.
*   **Negative Equity:** The negative equity is a significant concern, suggesting that the company has more liabilities than assets.
*   **Negative ROE:** The negative Return on Equity (ROE) reflects the company's inability to generate profit from shareholders' investments, further exacerbating the financial challenges.

### 7. Overall Summary

**Key Takeaways:**

*   **Significant Underperformance:** SBUX is significantly underperforming the S&P 500, with a concerning negative expected return.
*   **Negative News & Restructuring:** Store closures, job cuts, and restructuring are weighing heavily on the stock.
*   **Declining Profitability:** Profit margins are declining, and the company has negative equity and ROE.
*   **Conflicting Signals:** There is a conflict between the negative news and financial data and the analyst "Buy" consensus. The high MRI also seems to contradict the other concerning indicators.
*   **Downtrend:** The stock is in a short-term downtrend, confirmed by moving averages.

**Conclusion:**

Based on the provided data, Starbucks faces significant challenges. The negative news, declining profitability, and substantial underperformance compared to the S&P 500 raise serious concerns. While analysts maintain a "Buy" rating, the negative expected return and restructuring efforts warrant extreme caution. The high MRI should be critically evaluated in the context of other data, and shouldn't be the sole indicator for investment. A potential investor should thoroughly investigate the reasons behind the analyst consensus and the high MRI and consider the significant risks before investing in SBUX. It's important to understand the potential impact of the restructuring on the company's long-term performance and carefully monitor future earnings reports for signs of improvement.
